APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study.
- Authors
- Ramanan, V K; Risacher, S L; Nho, K; Kim, S; Swaminathan, S; Shen, L; Foroud, T M; Hakonarson, H; Huentelman, M J; Aisen, P S; Petersen, R C; Green, R C; Jack, C R; Koeppe, R A; Jagust, W J; Weiner, M W; Saykin, A J; Alzheimerβs Disease Neuroimaging Initiative
- Year
- 2014
- Journal
- Molecular psychiatry
- PMID
- 23419831
- DOI
- 10.1038/mp.2013.19
- PMCID
- PMC3661739
Deposition of amyloid-Ξ² (AΞ²) in the cerebral cortex is thought to be a pivotal event in Alzheimer's disease (AD) pathogenesis with a significant genetic contribution. Molecular imaging can provide an early noninvasive phenotype, but small samples have prohibited genome-wide association studies (GWAS) of cortical AΞ² load until now. We employed florbetapir ((18)F) positron emission tomography (PET) imaging to assess brain AΞ² levels in vivo for 555 participants from the Alzheimer's Disease Neuroimaging Initiative (ADNI). More than six million common genetic variants were tested for association to quantitative global cortical AΞ² load controlling for age, gender and diagnosis. Independent genome-wide significant associations were identified on chromosome 19 within APOE (apolipoprotein E) (rs429358, P=5.5 Γ 10(-14)) and on chromosome 3 upstream of BCHE (butyrylcholinesterase) (rs509208, P=2.7 Γ 10(-8)) in a region previously associated with serum BCHE activity. Together, these loci explained 15% of the variance in cortical AΞ² levels in this sample (APOE 10.7%, BCHE 4.3%). Suggestive associations were identified within ITGA6, near EFNA5, EDIL3, ITGA1, PIK3R1, NFIB and ARID1B, and between NUAK1 and C12orf75. These results confirm the association of APOE with AΞ² deposition and represent the largest known effect of BCHE on an AD-related phenotype. BCHE has been found in senile plaques and this new association of genetic variation at the BCHE locus with AΞ² burden in humans may have implications for potential disease-modifying effects of BCHE-modulating agents in the AD spectrum.
Quantile-quantile (Q-Q) plot of observed βlog10 p-values from the GWAS of cortical AΞ² load versus those expected under the null hypothesisThe Q-Q plot exhibits no evidence of genomic inflation (PLINK-calculated Ξ» = 1.00) or population stratification in the GWAS. An additive genetic model was used and age, gender, and diagnosis were applied as covariates. Analyses were restricted to subjects with non-Hispanic Caucasian (CEU or TSI) ancestry as determined by genetic clustering. Observed βlog10 p-values > 8 are represented along the top of the plot as red triangles, while all other values are represented as red dots.
LLM interpretation
This is a quantile-quantile (Q-Q) plot comparing observed $-\log_{10} p$-values against expected $-\log_{10} p$-values from a GWAS of cortical AΞ² load. The observed values (red dots and triangles) closely follow the diagonal null line for lower values before deviating upward, indicating significant associations. The plot includes a genomic inflation factor of $\lambda = 1.00$, and values exceeding 8 are marked as red triangles along the top axis.
Manhattan plot of observed βlog10 p-values from the GWAS of cortical AΞ² loadMore than six million SNPs were tested for association to global cortical AΞ² burden under an additive genetic model and applying age, gender, and diagnosis as covariates. Genome-wide significant associations (exceeding the threshold represented by the red line) were identified on chromosome 19 within APOE and its neighboring genes and on chromosome 3 at the BCHE locus. Suggestive associations (exceeding the threshold represented by the blue line) were identified on five additional chromosomes. Annotations are provided for genome-wide significant associations and for the top three suggestive associations.
LLM interpretation
This is a Manhattan plot showing the association between over six million SNPs and global cortical AΞ² burden across 22 chromosomes. The y-axis represents $-\log_{10}(p)$ values, with a red line indicating genome-wide significance ($p = 5 \times 10^{-8}$) and a blue line indicating suggestive association ($p = 5 \times 10^{-6}$). Significant peaks are identified on chromosome 19 (including *APOE*, *APOC1*, *PVRL2*, and *TOMM40*) and chromosome 3 (near *BCHE*), with several suggestive associations labeled on other chromosomes.
Regional association plots for the loci exhibiting genome-wide significant association to cortical AΞ² burdenMagnified association plots are displayed for the regions around A) rs429358 within APOE and B) rs509208 at the BCHE locus. SNPs are plotted based on their GWAS βlog10 p-values (left vertical axis) and their genomic position (NCBI build 36). Genes in these regions are labeled with arrows denoting their 5β²-to-3β² orientation, and the red color scale of r2 values is used to label SNPs based on their degree of linkage disequilibrium with the annotated peak SNP. Recombination rates calculated from 1000 Genomes Project reference data are also displayed in a blue line corresponding to the right vertical axis.
LLM interpretation
This figure consists of two regional association plots (Manhattan-style plots) showing the association of SNPs with cortical AΞ² burden near the *APOE* (A) and *BCHE* (B) loci. The x-axes represent genomic positions (hg18), the left y-axes show observed $-\log_{10}(p)$ values, and the right y-axes show recombination rates (blue line). Peak SNPs (rs429358 and rs509208) are highlighted as red diamonds with their respective p-values, while other SNPs are color-coded by linkage disequilibrium ($r^2$) with the peak SNP.
APOE Ξ΅4 and rs509208 (BCHE) appear to exhibit independent, additive effects on cortical AΞ² levelsMean cortical AΞ² levels (adjusted for age, gender, and diagnosis) Β± standard errors are displayed based on A) the number of APOE Ξ΅4 allele copies and B) rs509208 genotype. Presence of at least one copy of the Ξ΅4 allele was significantly associated with increased AΞ² burden (Cohenβs d = 0.71), as was presence of at least one copy of the minor allele (G) of rs509208 (Cohenβs d = 0.52). These loci appeared to exert additive effects on AΞ² levels (panel C): subjects having both risk factors exhibited significantly greater AΞ² burden than subjects having either factor in isolation, and no significant epistasis modeled as an interaction was identified.
LLM interpretation
This figure consists of three bar charts showing global cortical AΞ² load (SUVR) across different genetic markers. Panel A shows an increase in AΞ² load with the number of *APOE Ξ΅4* allele copies (0, 1, 2), and Panel B shows an increase based on *rs509208 (BCHE)* genotype (CC, CG, GG). Panel C demonstrates an additive effect, where the highest AΞ² load is observed in subjects possessing both risk factors [Ξ΅4(+)/BCHE(+)] compared to those with only one or neither.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| An endophenotype approach to the genetics of alcohol dependence: a genome wide association study of fast beta EEG in families of African ancestry. | 2017 | 28070124 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Systems biology of Alzheimer's Disease: a scoping review of key pathways and mechanisms. | Bice PJ et al. | β | 2026 | β |
| A PKCΞ· missense mutation enhances Golgi-localized signaling and is associated with recessively inherited familial Alzheimer's disease. | Gauron MC et al. | β | 2025 | β |
| Combating Genetic Heterogeneity for Polygenic Prediction of Susceptibility to Brain Ξ²-Amyloid Deposition: Beyond <i>APOE</i>. | Ramanan VK et al. | β | 2025 | β |
| Image-and-Label Conditioning Latent Diffusion Model: Synthesizing A$\beta$-PET From MRI for Detecting Amyloid Status. | Ou Z et al. | β | 2025 | β |
| Combining Experimental and Computational Methods to Produce Conjugates of Anticholinesterase and Antioxidant Pharmacophores with Linker Chemistries Affecting Biological Activities Related to Treatment of Alzheimer's Disease. | Makhaeva GF et al. | β | 2024 | β |
| CYP1B1-RMDN2 Alzheimer's disease endophenotype locus identified for cerebral tau PET. | Nho K et al. | β | 2024 | β |
| Integrating amyloid and tau imaging with proteomics and genomics in Alzheimer's disease. | Vilkaite G et al. | β | 2024 | β |
| LATE, Hippocampal Sclerosis, and Primary Age-related Tauopathy. | Ramanan VK et al. | β | 2024 | β |
| Machine Learning Models of Polygenic Risk for Enhanced Prediction of Alzheimer Disease Endophenotypes. | Gunter NB et al. | β | 2024 | β |
| Molecular Signatures and Clinical Significance of Notch Signaling Pathway in Peripheral Blood of Patients with Alzheimer's Disease. | Jia D et al. | β | 2024 | β |
| Onset of Alzheimer disease in apolipoprotein Ι4 carriers is earlier in butyrylcholinesterase K variant carriers | Lane RM et al. | β | 2024 | β |
| Onset of Alzheimer disease in apolipoprotein Ι4 carriers is earlier in butyrylcholinesterase K variant carriers. | Lane RM et al. | β | 2024 | β |
| Uncovering the Oxidative Stress Mechanisms and Targets in Alzheimer's Disease by Integrating Phenotypic Screening Data and Polypharmacology Networks. | Zhou M et al. | β | 2024 | β |
| Unraveling the genetic architecture of blood unfolded p-53 among non-demented elderlies: novel candidate genes for early Alzheimer's disease. | Yaghoobi A et al. | β | 2024 | β |
| Association between the LRP1B and APOE loci and the development of Parkinson's disease dementia. | Real R et al. | β | 2023 | β |
| Astrocytic APOE4 genotype-mediated negative impacts on synaptic architecture in human pluripotent stem cell model. | Watanabe H et al. | β | 2023 | β |
| Clinical effects of novel susceptibility genes for beta-amyloid: a gene-based association study in the Korean population. | Kim BH et al. | β | 2023 | β |
| Conjugates of Tacrine and Salicylic Acid Derivatives as New Promising Multitarget Agents for Alzheimer's Disease. | Makhaeva GF et al. | β | 2023 | β |
| Elevated Ghrelin Promotes Hippocampal Ghrelin Receptor Defects in Humanized Amyloid-Ξ² Knockin Mice During Aging. | Tian J et al. | β | 2023 | β |
| Genetics of Alzheimer's Disease in the African American Population. | Logue MW et al. | β | 2023 | β |
| Genetic underpinnings of brain structural connectome for young adults. | Zhao Y et al. | β | 2023 | β |
| Genome-wide association study in Alzheimer's disease: a bibliometric and visualization analysis. | Zhang J et al. | β | 2023 | β |
| Genome-wide association study of brain biochemical phenotypes reveals distinct genetic architecture of Alzheimer's disease related proteins. | Oatman SR et al. | β | 2023 | β |
| The Association of Selected GWAS Reported AD Risk Loci with CSF Biomarker Levels and Cognitive Decline in Slovenian Patients. | Vogrinc D et al. | β | 2023 | β |
| The structural modification and biological evaluation of tetrahydrothienopyridine derivatives as selective BChE inhibitors. | Chen T et al. | β | 2023 | β |
| A review of brain imaging biomarker genomics in Alzheimer's disease: implementation and perspectives. | Li L et al. | β | 2022 | β |
| Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: <i>N</i>-Functionalization Determines the Multitarget Anti-Alzheimer's Activity Profile. | Makhaeva GF et al. | β | 2022 | β |
| Genome-Wide association study of quantitative biomarkers identifies a novel locus for alzheimer's disease at 12p12.1. | Lee B et al. | β | 2022 | β |
| New Multifunctional Agents for Potential Alzheimer's Disease Treatment Based on Tacrine Conjugates with 2-Arylhydrazinylidene-1,3-Diketones. | Elkina NA et al. | β | 2022 | β |
| Pharmacogenetic Analyses of Therapeutic Effects of Lipophilic Statins on Cognitive and Functional Changes in Alzheimer's Disease. | de Oliveira FF et al. | β | 2022 | β |
| Polygenic Scores of Alzheimer's Disease Risk Genes Add Only Modestly to APOE in Explaining Variation in Amyloid PET Burden. | Ramanan VK et al. | β | 2022 | β |
| The Big Picture of Neurodegeneration: A Meta Study to Extract the Essential Evidence on Neurodegenerative Diseases in a Network-Based Approach. | Ruffini N et al. | β | 2022 | β |
| The heritability of amyloid burden in older adults: the Older Australian Twins Study. | Koncz R et al. | β | 2022 | β |
| Young Adults with a Parent with Dementia Show Early Abnormalities in Brain Activity and Brain Volume in the Hippocampus: A Matched Case-Control Study. | McDonough IM et al. | β | 2022 | β |
| Blood <i>NCAPH2</i> Methylation Is Associated With Hippocampal Volume in Subjective Cognitive Decline With Apolipoprotein E Ξ΅4 Non-carriers. | Chen Y et al. | β | 2021 | β |
| Clinicopathological correlations and cholinesterase expression in early-onset familial Alzheimer's disease with the presenilin 1 mutation, Leu235Pro. | Cash MK et al. | β | 2021 | β |
| Genetic Variability in Molecular Pathways Implicated in Alzheimer's Disease: A Comprehensive Review. | Vogrinc D et al. | β | 2021 | β |
| Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging. | Yan Q et al. | β | 2021 | β |
| Identify Consistent Cross-Modality Imaging Genetic Patterns via Discriminant Sparse Canonical Correlation Analysis. | Wang M et al. | β | 2021 | β |
| Identifying novel genetic variants for brain amyloid deposition: a genome-wide association study in the Korean population. | Kim HR et al. | β | 2021 | β |
| Interaction of Exogenous Butyrylcholinesterase with Ξ²-Amyloid Plaques in 5XFAD/Butyrylcholinesterase-Knockout Mouse Brain. | Reid GA et al. | β | 2021 | β |
| Novel BuChE-IDO1 inhibitors from sertaconazole: Virtual screening, chemical optimization and molecular modeling studies. | Zhou Y et al. | β | 2021 | β |
| Plasma amyloid Ξ² levels are driven by genetic variants near APOE, BACE1, APP, PSEN2: A genome-wide association study in over 12,000 non-demented participants. | Damotte V et al. | β | 2021 | β |
| Quantitative endophenotypes as an alternative approach to understanding genetic risk in neurodegenerative diseases. | Farias FHG et al. | β | 2021 | β |
| Regulatory role of local tissue signal Del-1 in cancer and inflammation: a review. | Li M et al. | β | 2021 | β |
| Risk Variants in Three Alzheimer's Disease Genes Show Association with EEG Endophenotypes. | Macedo A et al. | β | 2021 | β |
| Association Between Common Variants in RBFOX1, an RNA-Binding Protein, and Brain Amyloidosis in Early and Preclinical Alzheimer Disease. | Raghavan NS et al. | β | 2020 | β |
| Brain Imaging Genomics: Integrated Analysis and Machine Learning. | Shen L et al. | β | 2020 | β |
| Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale. | Ruffini N et al. | β | 2020 | β |
| Conjugates of tacrine and 1,2,4-thiadiazole derivatives as new potential multifunctional agents for Alzheimer's disease treatment: Synthesis, quantum-chemical characterization, molecular docking, and biological evaluation. | Makhaeva GF et al. | β | 2020 | β |
| Defining the Neural Kinome: Strategies and Opportunities for Small Molecule Drug Discovery to Target Neurodegenerative Diseases. | Krahn AI et al. | β | 2020 | β |
| Detecting genetic associations with brain imaging phenotypes in Alzheimer's disease via a novel structured SCCA approach. | Du L et al. | β | 2020 | β |
| Detecting Shared Genetic Architecture Among Multiple Phenotypes by Hierarchical Clustering of Gene-Level Association Statistics. | McGuirl MR et al. | β | 2020 | β |
| Differential transcript usage in the Parkinson's disease brain. | Dick F et al. | β | 2020 | β |
| Dysregulated Fc gamma receptor-mediated phagocytosis pathway in Alzheimer's disease: network-based gene expression analysis. | Park YH et al. | β | 2020 | β |
| Factors influencing recovery from mild traumatic brain injury. | Johnson LW et al. | β | 2020 | β |
| Genome-wide association study of the level of blood components in Pekin ducks. | Zhu F et al. | β | 2020 | β |
| Genome-wide transcriptome analysis identifies novel dysregulated genes implicated in Alzheimer's pathology. | Nho K et al. | β | 2020 | β |
| Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study. | Chuang YF et al. | β | 2020 | β |
| MCC-SP: a powerful integration method for identification of causal pathways from genetic variants to complex disease. | Zhu Y et al. | β | 2020 | β |
| New Hybrids of 4-Amino-2,3-polymethylene-quinoline and <i>p</i>-Tolylsulfonamide as Dual Inhibitors of Acetyl- and Butyrylcholinesterase and Potential Multifunctional Agents for Alzheimer's Disease Treatment. | Makhaeva GF et al. | β | 2020 | β |
| Phosphoinositide-3-kinase regulatory subunit 1 gene polymorphisms are associated with schizophrenia and bipolar disorder in the Han Chinese population. | Huang J et al. | β | 2020 | β |
| Systems modeling of white matter microstructural abnormalities in Alzheimer's disease. | Horgusluoglu-Moloch E et al. | β | 2020 | β |
| Variants in <i>PPP2R2B</i> and <i>IGF2BP3</i> are associated with higher tau deposition. | Ramanan VK et al. | β | 2020 | β |
| A context-based ABC model for literature-based discovery. | Kim YH et al. | β | 2019 | β |
| A decade in psychiatric GWAS research. | Horwitz T et al. | β | 2019 | β |
| Association of Apolipoprotein E Ι4, Educational Level, and Sex With Tau Deposition and Tau-Mediated Metabolic Dysfunction in Older Adults. | Ramanan VK et al. | β | 2019 | β |
| Butyrylcholinesterase Protein Ends in the Pathogenesis of Alzheimer's Disease-Could <i>BCHE</i> Genotyping Be Helpful in Alzheimer's Therapy? | Jasiecki J et al. | β | 2019 | β |
| Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies. | Sharma P et al. | β | 2019 | β |
| DEL-1-Regulated Immune Plasticity and Inflammatory Disorders. | Hajishengallis G et al. | β | 2019 | β |
| Discovery of New Selective Butyrylcholinesterase (BChE) Inhibitors with Anti-AΞ² Aggregation Activity: Structure-Based Virtual Screening, Hit Optimization and Biological Evaluation. | Jiang CS et al. | β | 2019 | β |
| Formaldehyde, Epigenetics, and Alzheimer's Disease. | Wang F et al. | β | 2019 | β |
| Genome-wide association analysis of hippocampal volume identifies enrichment of neurogenesis-related pathways. | Horgusluoglu-Moloch E et al. | β | 2019 | β |
| Homomeric and Heteromeric AΞ² Species Exist in Human Brain and CSF Regardless of Alzheimer's Disease Status and Risk Genotype. | Lana E et al. | β | 2019 | β |
| Identification of exon skipping events associated with Alzheimer's disease in the human hippocampus. | Han S et al. | β | 2019 | β |
| Next Generation Sequencing Analysis in Early Onset Dementia Patients. | Bonvicini C et al. | β | 2019 | β |
| Rapamycin regulates cholesterol biosynthesis and cytoplasmic ribosomal proteins in hippocampus and temporal lobe of APP/PS1 mouse. | Wang X et al. | β | 2019 | β |
| Short-term adverse effects of the apolipoprotein E Ξ΅4 allele over language function and executive function in healthy older adults. | Li W et al. | β | 2019 | β |
| A novel SCCA approach via truncated β1-norm and truncated group lasso for brain imaging genetics. | Du L et al. | β | 2018 | β |
| Exploring APOE genotype effects on Alzheimer's disease risk and amyloid Ξ² burden in individuals with subjective cognitive decline: The FundacioACE Healthy Brain Initiative (FACEHBI) study baseline results. | Moreno-Grau S et al. | β | 2018 | β |
| Genetic study of multimodal imaging Alzheimer's disease progression score implicates novel loci. | Scelsi MA et al. | β | 2018 | β |
| <i>CYP2C19</i> variant mitigates Alzheimer disease pathophysiology in vivo and postmortem. | Benedet AL et al. | β | 2018 | β |
| Lack of genetic support for shared aetiology of Coronary Artery Disease and Late-onset Alzheimer's disease. | Grace C et al. | β | 2018 | β |
| Nutrient Sensing, Signaling and Ageing: The Role of IGF-1 and mTOR in Ageing and Age-Related Disease. | Johnson SC | β | 2018 | β |
| Susceptibility of brain atrophy to <i>TRIB3</i> in Alzheimer's disease, evidence from functional prioritization in imaging genetics. | Lorenzi M et al. | β | 2018 | β |
| Adult neurogenesis and neurodegenerative diseases: A systems biology perspective. | Horgusluoglu E et al. | β | 2017 | β |
| An endophenotype approach to the genetics of alcohol dependence: a genome wide association study of fast beta EEG in families of African ancestry. | Meyers JL et al. | β | 2017 | β |
| Butyrylcholinesterase-knockout reduces fibrillar Ξ²-amyloid and conserves <sup>18</sup>FDG retention in 5XFAD mouse model of Alzheimer's disease. | DeBay DR et al. | β | 2017 | β |
| CSF ApoE predicts clinical progression in nondemented APOEΞ΅4 carriers. | van Harten AC et al. | β | 2017 | β |
| Genome-wide network-based pathway analysis of CSF t-tau/AΞ²1-42 ratio in the ADNI cohort. | Cong W et al. | β | 2017 | β |
| Genome-wide significant, replicated and functional risk variants for Alzheimer's disease. | Guo X et al. | β | 2017 | β |
| Haplotype-based association analysis of general cognitive ability in Generation Scotland, the English Longitudinal Study of Ageing, and UK Biobank. | Howard DM et al. | β | 2017 | β |
| Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load. | Grothe MJ et al. | β | 2017 | β |
| Novel conjugates of aminoadamantanes with carbazole derivatives as potential multitarget agents for AD treatment. | Bachurin SO et al. | β | 2017 | β |
| Opposing effects of progranulin deficiency on amyloid and tau pathologies via microglial TYROBP network. | Takahashi H et al. | β | 2017 | β |
| Quantification of Butyrylcholinesterase Activity as a Sensitive and Specific Biomarker of Alzheimer's Disease. | Macdonald IR et al. | β | 2017 | β |
| Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials. | Weiner MW et al. | β | 2017 | β |
| Response to the commentary on 'A genome-wide association study in Caucasian women suggests the involvement of HLA gene in the severity of facial solar lentigines'. | Laville V et al. | β | 2017 | β |
| State of Play in Alzheimer's Disease Genetics. | Zhu JB et al. | β | 2017 | β |
| Targeted neurogenesis pathway-based gene analysis identifies ADORA2A associated with hippocampal volume in mild cognitive impairment and Alzheimer's disease. | Horgusluoglu-Moloch E et al. | β | 2017 | β |
| TOMM40 and APOE Gene Expression and Cognitive Decline in Japanese Alzheimer's Disease Subjects. | Mise A et al. | β | 2017 | β |
| Transcriptome-wide piRNA profiling in human brains of Alzheimer's disease. | Qiu W et al. | β | 2017 | β |
| ABCA7 Genotypes Confer Alzheimer's Disease Risk by Modulating Amyloid-Ξ² Pathology. | Zhao QF et al. | β | 2016 | β |
| Amyloid-Ξ² peptides act as allosteric modulators of cholinergic signalling through formation of soluble BAΞ²ACs. | Kumar R et al. | β | 2016 | β |
| An Overview of Genome-Wide Association Studies in Alzheimer's Disease. | Shen L et al. | β | 2016 | β |
| Association of Butyrylcholinesterase-K Allele and Apolipoprotein E Ι4 Allele with Cognitive Decline in Dementia with Lewy Bodies and Alzheimer's Disease. | Vijayaraghavan S et al. | β | 2016 | β |
| Butyrylcholinesterase K and Apolipoprotein E-Ι4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects. | De Beaumont L et al. | β | 2016 | β |
| Genes associated with Alzheimer's disease: an overview and current status. | Giri M et al. | β | 2016 | β |
| Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba Nigerians. | Kim S et al. | β | 2016 | β |
| Genome research in pre-dementia stages of Alzheimer's disease. | Moreno-Grau S et al. | β | 2016 | β |
| Immunohistochemical analysis of hippocampal butyrylcholinesterase: Implications for regional vulnerability in Alzheimer's disease. | Mizukami K et al. | β | 2016 | β |
| Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer's disease mouse models. | Zhao L et al. | β | 2016 | β |
| Quantitative multimodal multiparametric imaging in Alzheimer's disease. | Zhao Q et al. | β | 2016 | β |
| Reduced fibrillar Ξ²-amyloid in subcortical structures in a butyrylcholinesterase-knockout Alzheimer disease mouse model. | Darvesh S et al. | β | 2016 | β |
| Structured sparse canonical correlation analysis for brain imaging genetics: an improved GraphNet method. | Du L et al. | β | 2016 | β |
| Structured sparse CCA for brain imaging genetics via graph OSCAR. | Du L et al. | β | 2016 | β |
| The Relieving Effects of BrainPower Advanced, a Dietary Supplement, in Older Adults with Subjective Memory Complaints: A Randomized, Double-Blind, Placebo-Controlled Trial. | Zhu J et al. | β | 2016 | β |
| 2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception. | Weiner MW et al. | β | 2015 | β |
| Alzheimer's Disease: Genomics and Beyond. | Song F et al. | β | 2015 | β |
| Antagonistic effects of IL-17 and D-resolvins on endothelial Del-1 expression through a GSK-3Ξ²-C/EBPΞ² pathway. | Maekawa T et al. | β | 2015 | β |
| Butyrylcholinesterase-knockout reduces brain deposition of fibrillar Ξ²-amyloid in an Alzheimer mouse model. | Reid GA et al. | β | 2015 | β |
| DEL-1 restrains osteoclastogenesis and inhibits inflammatory bone loss in nonhuman primates. | Shin J et al. | β | 2015 | β |
| Developmental endothelial locus-1 is a homeostatic factor in the central nervous system limiting neuroinflammation and demyelination. | Choi EY et al. | β | 2015 | β |
| Epistasis analysis links immune cascades and cerebral amyloidosis. | Benedet AL et al. | β | 2015 | β |
| FASTKD2 is associated with memory and hippocampal structure in older adults. | Ramanan VK et al. | β | 2015 | β |
| Genetic Interactions Explain Variance in Cingulate Amyloid Burden: An AV-45 PET Genome-Wide Association and Interaction Study in the ADNI Cohort. | Li J et al. | β | 2015 | β |
| Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans. | Saykin AJ et al. | β | 2015 | β |
| GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP. | Ramanan VK et al. | β | 2015 | β |
| Impact of the Alzheimer's Disease Neuroimaging Initiative, 2004 to 2014. | Weiner MW et al. | β | 2015 | β |
| Introduction to special issue: Overview of Alzheimer's Disease Neuroimaging Initiative. | Weiner MW et al. | β | 2015 | β |
| In-vivo brain neuroimaging provides a gateway for integrating biological and clinical biomarkers of Alzheimer's disease. | Cui J et al. | β | 2015 | β |
| New suggestive genetic loci and biological pathways for attention function in adult attention-deficit/hyperactivity disorder. | Alemany S et al. | β | 2015 | β |
| No evidence of association between variant rs2075650 in lipid metabolism-related locus APOE/TOMM40 and advanced age-related macular degeneration in Han Chinese population. | Kan M et al. | β | 2015 | β |
| On the central role of brain connectivity in neurodegenerative disease progression. | Iturria-Medina Y et al. | β | 2015 | β |
| Variations in the FRA10AC1 Fragile Site and 15q21 Are Associated with Cerebrospinal Fluid AΞ²1-42 Level. | Li QS et al. | β | 2015 | β |
| Wittig Reaction: Domino Olefination and Stereoselectivity DFT Study. Synthesis of the Miharamycins' Bicyclic Sugar Moiety. | Cachatra V et al. | β | 2015 | β |
| A distinct subfraction of AΞ² is responsible for the high-affinity Pittsburgh compound B-binding site in Alzheimer's disease brain. | Matveev SV et al. | β | 2014 | β |
| Alzheimer's disease genetics: from the bench to the clinic. | Karch CM et al. | β | 2014 | β |
| Apolipoprotein E and lipid homeostasis in the etiology and treatment of sporadic Alzheimer's disease. | Poirier J et al. | β | 2014 | β |
| Apolipoprotein E in Alzheimer's disease: an update. | Yu JT et al. | β | 2014 | β |
| Atherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculature. | Lathe R et al. | β | 2014 | β |
| Epidemic spreading model to characterize misfolded proteins propagation in aging and associated neurodegenerative disorders. | Iturria-Medina Y et al. | β | 2014 | β |
| Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study. | Doraiswamy PM et al. | β | 2014 | β |
| Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers. | Shen L et al. | β | 2014 | β |
| Genetic modification of the relationship between phosphorylated tau and neurodegeneration. | Hohman TJ et al. | β | 2014 | β |
| Genetic modifiers of cognitive maintenance among older adults. | Yokoyama JS et al. | β | 2014 | β |
| Interactions between GSK3Ξ² and amyloid genes explain variance in amyloid burden. | Hohman TJ et al. | β | 2014 | β |
| The alternative splicing of the apolipoprotein E gene is unperturbed in the brains of Alzheimer's disease patients. | Mills JD et al. | β | 2014 | β |
| Transcriptome-guided amyloid imaging genetic analysis via a novel structured sparse learning algorithm. | Yan J et al. | β | 2014 | β |
| Associations between white matter hyperintensities and Ξ² amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI. | Chao LL et al. | β | 2013 | β |
| Brain investigation and brain conceptualization. | Redolfi A et al. | β | 2013 | β |
| Integrative genomics identifies APOE Ξ΅4 effectors in Alzheimer's disease. | Rhinn H et al. | β | 2013 | β |
| Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders. | Ramanan VK et al. | β | 2013 | β |